Cargando…
473. Clinical Outcomes of a Pediatric COVID Monoclonal Antibody Program based at an Urban Academic Center
BACKGROUND: Growing clinical evidence in adults has demonstrated use of COVID monoclonal antibody (mAB) therapy results in a reduction of hospitalization and/or emergency room (ER) visits with the greatest benefit following early administration. While the FDA has authorized use of mAB therapy in chi...
Autores principales: | Lee, Philip J, Cruz, Carlos, Anosike, I J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690654/ http://dx.doi.org/10.1093/ofid/ofab466.672 |
Ejemplares similares
-
558. Implementation and Outcomes of a COVID-19 Monoclonal Antibody Treatment Program in an Urban Safety-net Community Hospital
por: Mena Lora, Alfredo J, et al.
Publicado: (2021) -
1130. Impact of a New Pediatric Antibiotic Stewardship Program on Ceftriaxone Use at an Academic Medical Center
por: Evans, Derek, et al.
Publicado: (2021) -
1814. Retrospective Study of Skin and Soft Tissue Actinomycosis in an Urban Pediatric Academic Medical Center
por: Demirhan, Salih, et al.
Publicado: (2023) -
526. Implementation of Use of Monoclonal Antibody Therapy in a Large Academic Center for the Outpatient Treatment of Covid-19: Impact on 30 Day Hospitalization Rates, ED Visits and Death
por: Bhimani, Azra, et al.
Publicado: (2021) -
473. Using Serosurveillance for SARS-CoV-2 to Conserve PCR Tests in a Resource Constrained Combat Environment
por: White, Brian K, et al.
Publicado: (2020)